CD276 and squamous cell carcinoma: Among NSCLC subtypes, B7-H3 expression was significantly more common in squamous carcinoma compared to adenocarcinoma (95% vs. 49%, p < 0.001 [173], p = 0.048 [170], p = 0.004 [174]).